Conversely, Muc13−/− mice are more susceptible to acute DSS-induced colitis by promoting epithelial cell apoptosis but deficiency of Muc13 expression during chronic colitis reduced the risk for tumor formation in azoxymethane (AOM)/DSS-treated mice [8,15]. This evidence concerns the gene MUC13 and neoplasm.